The global hemodynamic monitoring systems market is estimated to be valued at US$ 1,094.5 million in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030).
Figure 1. Global Hemodynamic Monitoring Systems Market Share (%), by Product Type, 2022
Global Hemodynamic Monitoring Systems Market - Drivers
Adoption of inorganic strategies such as product launches by key market players are expected to drive the global hemodynamic monitoring systems market over the forecast period. For instance, in May 2019, LiDCo Group, a subsidiary of Masimo, a medical technology company, announced that they had launched LiDCO rapid v3. LiDCO rapid v3 is a non-invasive hemodynamic monitoring system which is used to monitor cardiac output.
Market- Trends
Figure 2. Global Hemodynamic Monitoring Systems Market Value (US$ Million), by Region, 2022
Hemodynamic Monitoring Systems Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients